Effect of synthetic and bovine milk conjugated linoleic acid (CLA) on immune function : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Nutrition Science at Massey University by Zhao, Hui
Copyright is owned by the Author of the thesis.  Permission is given for 
a copy to be downloaded by an individual for the purpose of research and 
private study only.  The thesis may not be reproduced elsewhere without 
the permission of the Author. 
 
Effect of synthetic and bovine milk 
conjugated linoleic acid (CLA) on 
immune function 
A thesis presented in partial fulfilment of the requirements for 
the degree of Master of Science in Nutrition Science 
at Massey University, New Zealand 
HUIZHAO 
1999 
Effect of synthetic and bovine milk 
conjugated linoleic acid (CLA) on 
immune function 
A thesis presented in partial fulfilment of the requirements for 
the degree of Master of Science in Nutrition Science 
at Massey University, New Zealand 
HUIZHAO 
1999 
ABSTRACT 
CLA is a collective name for a mixture of positional and geometrical isomers of linoleic acid 
( c-9, c-12-octadecadioenic acid) which possess conjugated double bonds. CLA occurs in a 
variety of foods, but is present at higher concentrations in products from ruminants. Milk fat 
is the richest natural source of CLA. The objective of this research was to examine the 
immunomodulatory properties of CLA (both synthetic and natural CLA derived from bovine 
milk fat). Two experiments were conducted at the Milk and Health Research Centre, Massey 
University, Palmerston North, New Zealand. 
The aim of the first experiment was to investigate the dose effect of different concentrations 
of synthetic CLA (Tonalin) on immune function . Mice were fed either skim milk powder 
based diet or the same diet supplemented with 0.1, 0.25, 0.5, 1.0 or 2.0% synthetic CLA 
(Tonalin) by weight. Animals were immunised orally with a mixture of polio vaccine in 
sodium bicarbonate (25 µl) and subcutaneously with Fluvax and Tetanus toxoid vaccine on 
days 7 and 21. After 4 weeks feeding, mice were euthanased by isoflurane overdose. 
Various immune parameters were measured and the results showed that synthetic CLA 
(Tonalin) enhanced a range of immune functions. Synthetic CLA stimulated PHA induced T 
lymphocyte proliferation at 0.25, 0.5 and 1.0% as compared with the control group (p < 
0.05). Synthetic CLA enhanced macrophage phagocytosis in a dose dependent manner. 
Synthetic CLA enhanced antibody responses (mucosa! and systemic) to vaccines (polio 
vaccine, Fluvax and Tetanus toxoid). Natural killer cell activity was significantly enhanced 
in mice fed 0.25 and 0.5% CLA. In general, 0.25% CLA was regarded as the best CLA level 
which achieved optimal immunoregulating effects. 
The aim of the second experiment was to examine the effect of natural CLA derived from 
milk fat on immune responses in mice. Mice were fed a skim milk powder (SMP) based 
diet. The control diet was skim milk powder only, without any CLA or milk fat 
supplementation. The dietary treatments were: ordinary milk fat, fractionated milk fat ( 1 st 
stage), 0.2% synthetic CLA (Tonalin) and CLA enriched milk fat. Animals were fed these 
diets for 28 days. Mice were immunised orally with a mixture of polio 
vaccine/ovalbumin/cholera toxin in sodium bicarbonate on days 7, 14 and 21 and 
subcutaneously with Fluvax and ADT (Diptheria and Tetanus toxoid vaccine) on days 7 and 
21. Natural CLA was found to stimulate PHA and Con A induced T lymphocyte 
blastogenesis. Supplementation with natural CLA also led to increased antibody responses 
to vaccines and increased CD25+ populations in peripheral blood in mice. Natural CLA also 
enhanced macrophage phagocytosis. Synthetic CLA enhanced a range of immune functions 
which is consistent with the results in the first experiment. 
It is noted that although the CLA content is low in milk fat, the natural CLA derived from 
milk fat expressed potent effects in enhancing the growth of immune cells and promoting a 
range of immune functions in mice. 
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